ResearcherGarvan Institute of Medical ResearchNo recent work listed
Kurt I. Anderson
Matched on ORCID iD 0000-0002-9324-9598; OpenAlex author ID A5081803701. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 24
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 2 papers
Papers 6
- Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Co-author DOI 10.1126/scitranslmed.aai8504↗
- ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. Co-author DOI 10.15252/emmm.201606743↗
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug effic… Co-author DOI 10.15252/emmm.201404827↗
- Targeting mTOR dependency in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2013-306202↗
- Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. Last author DOI 10.1158/0008-5472.can-12-4545↗
- Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. Last author DOI 10.1158/0008-5472.can-10-2267↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jennifer P. Morton · 5 shared papers, 2011–2017 · strength 0.18
- Paper ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. DOI 10.15252/emmm.201606743↗
- Paper Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abro… DOI 10.15252/emmm.201404827↗
- Paper Targeting mTOR dependency in pancreatic cancer. DOI 10.1136/gutjnl-2013-306202↗
- Owen James Sansom · 4 shared papers, 2011–2015 · strength 0.12
- Paper Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abro… DOI 10.15252/emmm.201404827↗
- Paper Targeting mTOR dependency in pancreatic cancer. DOI 10.1136/gutjnl-2013-306202↗
- Paper Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. DOI 10.1158/0008-5472.can-12-4545↗
- Thomas R. Jeffry Evans · 3 shared papers, 2013–2015 · strength 0.10
- Paper Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abro… DOI 10.15252/emmm.201404827↗
- Paper Targeting mTOR dependency in pancreatic cancer. DOI 10.1136/gutjnl-2013-306202↗
- Paper Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. DOI 10.1158/0008-5472.can-12-4545↗
- Paul Timpson · 3 shared papers, 2011–2015 · strength 0.09
- Paper Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abro… DOI 10.15252/emmm.201404827↗
- Paper Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. DOI 10.1158/0008-5472.can-12-4545↗
- Paper Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. DOI 10.1158/0008-5472.can-10-2267↗
- Michael F. Olson · 2 shared papers, 2011–2017 · strength 0.08
- Karin A. Oien · 2 shared papers, 2014–2015 · strength 0.07
- Nigel Balfour Jamieson · 2 shared papers, 2014–2015 · strength 0.07
- Colin J. McKay · 2 shared papers, 2014–2015 · strength 0.07
- C. Ross Carter · 2 shared papers, 2014–2015 · strength 0.07
- David Kuang-Fu Chang · 2 shared papers, 2014–2015 · strength 0.07
- Andrew Victor Biankin · 2 shared papers, 2014–2015 · strength 0.07
- Nicola Rath · 1 shared paper, 2017 · strength 0.06
- Andreia V. Pinho · 1 shared paper, 2017 · strength 0.06
- Ilse Rooman · 1 shared paper, 2017 · strength 0.06
- Colin William Steele · 1 shared paper, 2015 · strength 0.04
- Janine Terra Erler · 1 shared paper, 2015 · strength 0.04
- Caroline J. Springer · 1 shared paper, 2015 · strength 0.04
- Peter J. Bailey · 1 shared paper, 2015 · strength 0.04
- Bryan W Miller · 1 shared paper, 2015 · strength 0.04
- Douglas C. Morran · 1 shared paper, 2014 · strength 0.03
- Christopher James Scarlett · 1 shared paper, 2014 · strength 0.03
- Sean Michael Grimmond · 1 shared paper, 2014 · strength 0.03
- Yingxiao Wang · 1 shared paper, 2013 · strength 0.03
- Max Nobis · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.